Predictors of Failure of Medical Management in Uncomplicated Type B Aortic Dissection.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
02 2019
Historique:
received: 17 11 2017
revised: 24 05 2018
accepted: 13 08 2018
pubmed: 8 10 2018
medline: 8 11 2019
entrez: 8 10 2018
Statut: ppublish

Résumé

Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes but is associated with a high incidence of failure. This study identified predictors of aortic intervention and mortality in uTBAD patients undergoing OMT. A retrospective review of the Emory University School of Medicine aortic database identified 314 uTBAD patients undergoing OMT from 2000 to 2016. Two hundred sixty-three (84%) patients had imaging at presentation analyzed for maximum aortic diameters (ADs), false lumen (FL) status, and visceral vessel perfusion. Cox proportional hazards models were constructed to estimate hazards ratios (HRs) and identify predictors of OMT failure. The mean age of patients was 58 ± 12 years, and 67% were men. FL status was patent in 59.4%, partially thrombosed in 39.8%, and completely thrombosed in 0.8% of patients. Over a median follow-up of 5.6 (interquartile range, 1.4 to 8.5) years, 44.9% of patients failed OMT and underwent intervention (n = 58 open, n = 83 endovascular). The estimated incidence of OMT failure was 46%. Multivariate analysis identified the presence of diabetes, renal failure, DeBakey 3B dissection, and a descending thoracic AD of 4.5 cm or greater (HR, 1.39; 95% confidence interval, 1.24 to 1.56; p < 0.001) to be independent predictors of failure of OMT. FL status or the distribution of visceral vessels arising from the FL did not predict OMT failure. There is a significant incidence of OMT failure in uTBAD patients. A descending thoracic AD of 4.5 cm or greater at the time of diagnosis is an independent predictor of failure of OMT.

Sections du résumé

BACKGROUND
Optimal medical therapy (OMT) for uncomplicated type B aortic dissection (uTBAD) provides excellent short-term outcomes but is associated with a high incidence of failure. This study identified predictors of aortic intervention and mortality in uTBAD patients undergoing OMT.
METHODS
A retrospective review of the Emory University School of Medicine aortic database identified 314 uTBAD patients undergoing OMT from 2000 to 2016. Two hundred sixty-three (84%) patients had imaging at presentation analyzed for maximum aortic diameters (ADs), false lumen (FL) status, and visceral vessel perfusion. Cox proportional hazards models were constructed to estimate hazards ratios (HRs) and identify predictors of OMT failure.
RESULTS
The mean age of patients was 58 ± 12 years, and 67% were men. FL status was patent in 59.4%, partially thrombosed in 39.8%, and completely thrombosed in 0.8% of patients. Over a median follow-up of 5.6 (interquartile range, 1.4 to 8.5) years, 44.9% of patients failed OMT and underwent intervention (n = 58 open, n = 83 endovascular). The estimated incidence of OMT failure was 46%. Multivariate analysis identified the presence of diabetes, renal failure, DeBakey 3B dissection, and a descending thoracic AD of 4.5 cm or greater (HR, 1.39; 95% confidence interval, 1.24 to 1.56; p < 0.001) to be independent predictors of failure of OMT. FL status or the distribution of visceral vessels arising from the FL did not predict OMT failure.
CONCLUSIONS
There is a significant incidence of OMT failure in uTBAD patients. A descending thoracic AD of 4.5 cm or greater at the time of diagnosis is an independent predictor of failure of OMT.

Identifiants

pubmed: 30292842
pii: S0003-4975(18)31355-9
doi: 10.1016/j.athoracsur.2018.08.012
pmc: PMC6408689
mid: NIHMS1015038
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-498

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR002382
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States

Informations de copyright

Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Références

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1163-70
pubmed: 17976444
Ann Thorac Surg. 2017 Jun;103(6):1878-1885
pubmed: 27993378
J Vasc Surg. 2016 Dec;64(6):1560-1568
pubmed: 27707621
J Vasc Surg. 2018 Jan;67(1):78-84
pubmed: 28912006
J Am Coll Cardiol. 2016 Sep 6;68(10):1054-65
pubmed: 27585511
J Vasc Surg. 2014 Apr;59(4):1134-43
pubmed: 24661897
Ann Thorac Surg. 2014 Mar;97(3):767-73; discussion 773
pubmed: 24360090
Circulation. 2015 Aug 25;132(8):748-54
pubmed: 26304666
Ann Thorac Surg. 2004 Oct;78(4):1268-73
pubmed: 15464484
Ann Thorac Surg. 2018 Jan;105(1):31-38
pubmed: 28811003
J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S109-15; discussion S142-S146
pubmed: 21092775
J Vasc Surg. 2015 May;61(5):1192-8
pubmed: 25659458
Ann Thorac Surg. 2016 Dec;102(6):1925-1932
pubmed: 27424468
N Engl J Med. 2007 Jul 26;357(4):349-59
pubmed: 17652650
Ann Thorac Surg. 2014 Feb;97(2):588-95
pubmed: 24360089
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2155-2160.e1
pubmed: 24793648
Circ Cardiovasc Imaging. 2017 Apr;10(4):
pubmed: 28360261
Eur J Vasc Endovasc Surg. 2014 Oct;48(4):363-71
pubmed: 24952999
Circ Cardiovasc Interv. 2013 Aug;6(4):407-16
pubmed: 23922146
Circulation. 2006 Nov 21;114(21):2226-31
pubmed: 17101856
J Thorac Cardiovasc Surg. 2015 Feb;149(2 Suppl):S151-6
pubmed: 25466855

Auteurs

Xiaoying Lou (X)

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.

Yazan M Duwayri (YM)

Division of Vascular and Endovascular Therapy, Emory University School of Medicine, Atlanta, Georgia.

Edward P Chen (EP)

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.

William D Jordan (WD)

Division of Vascular and Endovascular Therapy, Emory University School of Medicine, Atlanta, Georgia.

Jessica Forcillo (J)

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.

Carl A Zehner (CA)

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia.

Bradley G Leshnower (BG)

Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia. Electronic address: bleshno@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH